Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
88.78
+2.48 (2.87%)
At close: Mar 9, 2026, 4:00 PM EDT
88.75
-0.03 (-0.03%)
After-hours: Mar 9, 2026, 4:54 PM EDT
Mirum Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | -23.36 | -87.94 | -163.42 | -135.67 | -83.99 | Upgrade
|
| Depreciation & Amortization | 24.24 | 23.63 | 10.83 | 3.24 | 0.6 | Upgrade
|
| Other Amortization | 1.74 | 1.66 | 1.12 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -108 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.14 | Upgrade
|
| Stock-Based Compensation | 71.42 | 48.44 | 35.02 | 27.01 | 23.09 | Upgrade
|
| Other Operating Activities | 1.5 | 1.94 | 64.72 | 6.33 | 18.7 | Upgrade
|
| Change in Accounts Receivable | -48.06 | -11.43 | -43.97 | -20.73 | - | Upgrade
|
| Change in Inventory | -8.45 | -3.17 | -0.97 | -3.45 | -0.5 | Upgrade
|
| Change in Accounts Payable | 50.1 | 40.31 | 30.78 | 7.64 | 22.66 | Upgrade
|
| Change in Other Net Operating Assets | -13.32 | -3.13 | -5.05 | -4.51 | -5.18 | Upgrade
|
| Operating Cash Flow | 55.83 | 10.33 | -70.94 | -120.14 | -132.76 | Upgrade
|
| Operating Cash Flow Growth | 440.70% | - | - | - | - | Upgrade
|
| Capital Expenditures | -0.95 | -0.99 | -0.11 | -0.28 | -0.02 | Upgrade
|
| Cash Acquisitions | - | - | -212.76 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -20 | -20 | - | -19 | Upgrade
|
| Investment in Securities | -23 | -69.13 | 125.67 | 7.98 | -40.43 | Upgrade
|
| Other Investing Activities | - | - | - | - | 108 | Upgrade
|
| Investing Cash Flow | -23.95 | -90.13 | -107.2 | 7.7 | 48.55 | Upgrade
|
| Long-Term Debt Issued | - | - | 305.3 | - | - | Upgrade
|
| Total Debt Issued | - | - | 305.3 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 305.3 | - | - | Upgrade
|
| Issuance of Common Stock | 40.14 | 17.7 | 227.15 | 114.64 | 9.01 | Upgrade
|
| Other Financing Activities | - | - | -195.86 | -5.55 | 64.45 | Upgrade
|
| Financing Cash Flow | 40.14 | 17.7 | 336.6 | 109.09 | 73.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.22 | -1.3 | -0.13 | 0.01 | -0 | Upgrade
|
| Net Cash Flow | 75.24 | -63.4 | 158.32 | -3.34 | -10.75 | Upgrade
|
| Free Cash Flow | 54.87 | 9.33 | -71.05 | -120.41 | -132.78 | Upgrade
|
| Free Cash Flow Growth | 488.01% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 10.53% | 2.77% | -38.12% | -156.26% | -693.81% | Upgrade
|
| Free Cash Flow Per Share | 1.09 | 0.20 | -1.74 | -3.54 | -4.38 | Upgrade
|
| Cash Interest Paid | 12.65 | 12.65 | 6.82 | - | - | Upgrade
|
| Cash Income Tax Paid | 2.16 | 1 | 0.13 | - | - | Upgrade
|
| Levered Free Cash Flow | 98.56 | 16.67 | -91.35 | -68.57 | -96.18 | Upgrade
|
| Unlevered Free Cash Flow | 105.81 | 23.95 | -83.03 | -58.59 | -85.19 | Upgrade
|
| Change in Working Capital | -19.72 | 22.59 | -19.22 | -21.05 | 16.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.